Ignite Creation Date:
2024-05-06 @ 8:27 AM
Last Modification Date:
2024-10-26 @ 12:00 PM
Study NCT ID:
NCT02737501
Status:
COMPLETED
Last Update Posted:
2021-08-20
First Post:
2016-03-30
Brief Title:
ALTA-1L Study A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive ALK Advanced Non-small Cell Lung Cancer NSCLC Participants
Sponsor:
Ariad Pharmaceuticals
Organization:
Takeda
Organization Data
Organization:
Takeda
Class:
INDUSTRY
Study ID:
AP26113-13-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ariad Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None